Neutralizing antibodies against vesicular stomatitis viruses (serotypes New Jersey and Indiana) in horses in Costa Rica
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Blickwede, M.; Dolz, G.; Herrero, M.V.; Tomlinson, S.M.; Salman, M.: Neutralizing antibodies against vesicular stomatitis viruses (serotypes New Jersey and Indiana) in horses in Costa Rica. In: Journal of Veterinary Diagnostic Investigation 14 (2002), Nr. 5, S. 438-441. DOI: https://doi.org/10.1177/104063870201400517
- Event
-
Veröffentlichung
- (where)
-
Hannover
- (who)
-
Gottfried Wilhelm Leibniz Universität Hannover
- (when)
-
2002
- Event
-
Veröffentlichung
- (where)
-
Hannover
- (who)
-
Technische Informationsbibliothek (TIB)
- (when)
-
2002
- DOI
-
10.15488/3024
- URN
-
urn:nbn:de:101:1-2020060306503259947492
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gottfried Wilhelm Leibniz Universität Hannover
- Technische Informationsbibliothek (TIB)
Time of origin
- 2002
Other Objects (12)
Vesicular-Stomatitis-Virus (Stamm Indiana) - Cytopathische Veränderungen in der Gewebekultur (HEp-2)
The nucleocapsid of vesicular stomatitis virus
Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited
Atomic model of vesicular stomatitis virus and mechanism of assembly
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
A Vesicular Stomatitis Virus‐Inspired DNA Nanocomplex for Ovarian Cancer Therapy
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus
Interferon Regulatory Factor-1 protects from fatal neurotropic infection with Vesicular Stomatitis Virus
Hydrodynamic characterization of a vesicular stomatitis virus-based oncolytic virus using analytical ultracentrifugation
Intronunabhängige Expression des Glykoproteins G des Vesicular-Stomatitis-Virus zur Pseudotypisierung lentiviraler Vektoren
Vesicular-Stomatitis-Virus (Stamm Indiana) - Cytopathische Veränderungen in der Gewebekultur (HEp-2)
The nucleocapsid of vesicular stomatitis virus
Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited
Atomic model of vesicular stomatitis virus and mechanism of assembly
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
A Vesicular Stomatitis Virus‐Inspired DNA Nanocomplex for Ovarian Cancer Therapy
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus
Interferon Regulatory Factor-1 protects from fatal neurotropic infection with Vesicular Stomatitis Virus
Hydrodynamic characterization of a vesicular stomatitis virus-based oncolytic virus using analytical ultracentrifugation
Intronunabhängige Expression des Glykoproteins G des Vesicular-Stomatitis-Virus zur Pseudotypisierung lentiviraler Vektoren
Vesicular-Stomatitis-Virus (Stamm Indiana) - Cytopathische Veränderungen in der Gewebekultur (HEp-2)
The nucleocapsid of vesicular stomatitis virus
Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited
Atomic model of vesicular stomatitis virus and mechanism of assembly
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
A Vesicular Stomatitis Virus‐Inspired DNA Nanocomplex for Ovarian Cancer Therapy
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus
Interferon Regulatory Factor-1 protects from fatal neurotropic infection with Vesicular Stomatitis Virus
Hydrodynamic characterization of a vesicular stomatitis virus-based oncolytic virus using analytical ultracentrifugation